Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer.
about
Biodegradable multiblock poly(N-2-hydroxypropyl)methacrylamide gemcitabine and paclitaxel conjugates for ovarian cancer cell combination treatmentEffects of sequential paclitaxel-carboplatin followed by gemcitabine-based chemotherapy compared with paclitaxel-carboplatin therapy administered to patients with advanced epithelial ovarian cancer: A retrospective, STROBE-compliant study.Cell surface protein glycosylation in cancer.Proteogenomic studies in epithelial ovarian cancer: established knowledge and future needs.Mixed Liposome Approach for Ratiometric and Sequential Delivery of Paclitaxel and Gemcitabine.
P2860
Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Phase II study of carboplatin ...... t for advanced ovarian cancer.
@ast
Phase II study of carboplatin ...... t for advanced ovarian cancer.
@en
type
label
Phase II study of carboplatin ...... t for advanced ovarian cancer.
@ast
Phase II study of carboplatin ...... t for advanced ovarian cancer.
@en
prefLabel
Phase II study of carboplatin ...... t for advanced ovarian cancer.
@ast
Phase II study of carboplatin ...... t for advanced ovarian cancer.
@en
P2093
P1476
Phase II study of carboplatin ...... t for advanced ovarian cancer.
@en
P2093
B Fitzharris
M Friedlander
P De Souza
P304
P356
10.1111/J.1525-1438.2007.00795.X
P577
2007-03-01T00:00:00Z